首页> 外国专利> METHOD FOR PREDICTION OF DEVELOPMENT OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION WITH CHRONIC CARDIAC INSUFFICIENCY AND HELICOBACTER PYLORI-NEGATIVE GASTROPATHIAS

METHOD FOR PREDICTION OF DEVELOPMENT OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION WITH CHRONIC CARDIAC INSUFFICIENCY AND HELICOBACTER PYLORI-NEGATIVE GASTROPATHIAS

机译:预测原发性高血压合并慢性心功能不全和幽门螺杆菌阴性胃病的患者的心血管并发症发生的方法

摘要

Method for prediction of development of cardiovascular complications in patients with arterial hypertension with chronic cardiac insufficiency includes determination of level of cytokines. In patients in which essential arterial hypertension with chronic cardiac insufficiency flows at background of helicobacter pylori-negative gastropathias development of cardiovascular complications is predicted by the values of median FNP-1 that is determined through monitoring of its levels, at that the moderate risk of development of cardiovascular complications one predicts at the value of the median FNP-1 80.04 pg/ml and lower, and high risk of development of cardiovascular complications one predicts at the level of median FNP-1 87.24 pg/ml and higher.
机译:预测患有慢性心脏功能不全的动脉高血压患者心血管并发症发生的方法包括确定细胞因子的水平。在患有慢性心脏功能不全的原发性高血压在幽门螺杆菌阴性胃炎的背景下流动的患者中,心血管并发症的发生由通过监测其水平确定的中值FNP-1值来预测,在这种情况下,中度发展风险心血管并发症的预测值是FNP-1的中位数值为80.04 pg / ml和更低,而心血管并发症发生的高风险是预测的FNP-1值为中值87.24 pg / ml和更高。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号